MedPro Group points to an HHS move letting pharmacies compound six peptides that lack FDA approval. Details are in the linked story.
Recap by typeshit. Post by MedPro Group on X.
Lincoln Journal Star reports FDA advisors are weighing whether seven unapproved peptides can be used in some compounded prescriptions.
The segment covers a federal draft policy that could open access to some injectable peptides, alongside proposed changes to infant formula nutrients.
The longevity researcher argues the FDA system has grown too slow and costly, saying it favors big drugmakers. He offers this as the reason reform efforts emerged.
TikTok's health content rules bar weight-management claims and GLP-1 promos, with removals or account penalties for creators who break them.
The Times looks at why gatherings built around peptides are becoming more common.
Avi Roy flags a preprint that pooled 10,052 people from five semaglutide trials and used a blood test to estimate heart age. It has not yet been peer reviewed.
Loading…